Harbour Trust & Investment Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.75M Sell
14,893
-184
-1% -$39.6K 0.36% 57
2026
Q1
$3.28M Sell
15,077
-491
-3% -$109K 0.35% 55
2025
Q4
$3.56M Sell
15,568
-183
-1% -$41.7K 0.36% 57
2025
Q3
$3.65M Sell
15,751
-1,171
-7% -$238K 0.38% 62
2025
Q2
$3.14M Buy
16,922
+9
+0.1% +$1.67K 0.35% 64
2025
Q1
$3.54M Sell
16,913
-1,483
-8% -$288K 0.43% 60
2024
Q4
$3.27M Sell
18,396
-535
-3% -$98.4K 0.37% 63
2024
Q3
$3.74M Sell
18,931
-488
-3% -$91.1K 0.43% 63
2024
Q2
$3.33M Sell
19,419
-498
-3% -$82.5K 0.4% 63
2024
Q1
$3.63M Sell
19,917
-242
-1% -$41.7K 0.46% 61
2023
Q4
$3.12M Buy
+20,159
New +$2.94M 0.44% 60

Other funds holding ABBV

Harbour Trust & Investment Management's ABBV Position: Q2 2026 in Review

Harbour Trust & Investment Management reduced its AbbVie (ABBV) stake by 1.2% in Q2 2026, selling an estimated $39.6K and leaving 14,893 shares worth $3.75M. The position accounts for 0.36% of the portfolio, ranked #57.

Harbour Trust & Investment Management first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 2,116 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Harbour Trust & Investment Management held 14,893 shares of AbbVie worth $3.75M as of Q2 2026.
  • Harbour Trust & Investment Management sold 184 AbbVie shares in Q2 2026, an estimated $39.6K.
  • AbbVie made up 0.36% of Harbour Trust & Investment Management's portfolio in Q2 2026, its #57 holding.
  • Harbour Trust & Investment Management first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 2,116 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Harbour Trust & Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.